Wed.Nov 16, 2022

article thumbnail

Working With Discount Cards and Manufacturer Coupons

Drug Topics

Discount cards and manufacturer coupons can cost pharmacies in the long run.

551
551
article thumbnail

New data show how insurers and middlemen shift Rx costs onto patients

PhRMA

There is only one place in the health care system where middlemen refuse to share negotiated prices with patients, and that’s at the pharmacy counter. A new report reveals how this harmful tactic leads to higher costs for patients.

Insurance 296
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Rinvoq’s Effectiveness in Treating Crohn’s, Ulcerative Colitis Shown in Studies

Drug Topics

New research illustrates the efficacy of upadacitinib for treating Crohn's and ulcerative colitis.

500
500
article thumbnail

To explore cancer’s genetic mysteries, researchers turn to ‘MACHETE’

PharmaVoice

A new CRISPR-based tool could help scientists understand and better treat cancer by revealing the complex genetic mutations that occur.

264
264
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

FDA Releases Notice on Safety and Effectiveness of Certain Nonprescription Naloxone Products

Drug Topics

We may be one step closer to nonprescription naloxone.

FDA 469
article thumbnail

Six ways I-MAK is lying about biopharma patents

PhRMA

The Arnold-Venture funded advocacy group Initiative for Medicines, Access & Knowledge, Inc. (or I-MAK) is on a global media tour, espousing their point of view on the patent system. Some experts and congressional leaders don’t buy the rhetoric, and neither should you.

263
263

More Trending

article thumbnail

The Promise & Pressures of Biologics R&D

Pharmacy Times

Generic small molecule drugs take advantage of abbreviated approval pathways and have markedly lower development costs compared to their reference products.

148
148
article thumbnail

Top U.S. addiction researcher calls for broad deregulation of methadone

STAT

BOSTON — The U.S. government’s top addiction researcher is calling for broad deregulation of methadone , a key drug used to treat opioid use disorder. American doctors should “absolutely” be allowed to prescribe methadone directly to patients, Nora Volkow, the director of the National Institute on Drug Abuse, said Wednesday.

144
144
article thumbnail

Study Finds Significant Drop in Vaccine Confidence During COVID-19 Pandemic

Pharmacy Times

In a 2019 survey, middle-aged participants were considerably more apprehensive about getting vaccinated than younger groups, which was not the case in the 2022 survey.

Vaccines 132
article thumbnail

Advanced therapies and the high-profile pricing dilemma

pharmaphorum

The advancements made in drug development over the last decade have seen the arrival of a number of treatments that offer one-time cures and more effective therapies for conditions in smaller patient populations. However, alongside this progress, Ben Hargreaves finds that there is also a conundrum over how to price these therapies. It is no secret that the drug development process for the pharmaceutical industry has undergone a major transition in the last few decades.

131
131
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Novel Migraine Treatment Shows Mixed Results in Phase 3 Efficacy Trial

Pharmacy Times

Investigational migraine drug produces significant effects on both freedom-from-pain and MBS-free endpoints at 3 hours post administration and at additional efficacy measurement timepoints of 4, 6, 12, 24 and 48 hours.

132
132
article thumbnail

Novartis said to be eyeing sale of ophthalmology, respiratory units

pharmaphorum

Novartis has already spun out its eyecare business Alcon, and is now considering the sale of its ophthalmology and respiratory medicines businesses as it continues a narrowing of its focus, according to media reports. A Bloomberg article citing people close to the matter claims that Novartis is engaged in early discussions about the sale of the two units, which could raise billions of dollars in capital that could be reinvested into the pharma group’s pipeline.

125
125
article thumbnail

“Diversity Equals Health”; A Diverse Gut Microbiome Could Be Driving Factor to Protect Against COVID-19

Pharmacy Times

Like using good nutrients to grow tomatoes in the soil, good nutrients and diverse microbes are important for our good gut health, or our gut's "garden," said a leading researcher.

132
132
article thumbnail

WHO, Uganda plan to test three candidate Ebola vaccines in outbreak

STAT

The World Health Organization and the government of Uganda plan to test three candidate Ebola vaccines in a clinical trial during the ongoing outbreak in the East African nation, Director-General Tedros Adhanom Ghebreyesus announced Wednesday, acting on the advice of experts convened by the global health agency. The first doses of vaccine should arrive in Uganda next week, Tedros said, though the WHO has not yet indicated a start date for the trial.

Vaccines 120
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Defining SARS-CoV-2 Bivalent Vaccines and Optimizing Protection Through Vaccination

Pharmacy Times

Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Jacinda Abdul-Mutakabbir, PharmD; and Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc; review what encompasses a bivalent vaccine and give their perspective on how to communicate the role of the vaccine in optimizing protection for patients.

Vaccines 132
article thumbnail

Opinion: Unseen mental health experts: people with mental illness

STAT

When I was seven years old, I watched as police carted my father out of the house and took him away. He had severe bipolar disorder and was experiencing what I know now to be an “episode”  of this mental illness. What I learned over the 40 years that my dad was alive is that he could foster a loving relationship despite not ever mastering his recurrent episodes.

117
117
article thumbnail

Study: FGFR mRNA Overexpression Occurs Frequently for Those With Cholangiocarcinoma

Pharmacy Times

Investigators also confirmed that FGFR2 fusion–positive tumors have a higher expression of FGFR2 but were not associated with higher expression of FGFR1, FGFR3, or FGFR4.

123
123
article thumbnail

Fentanyl isn’t just causing overdoses. It’s making it harder to start addiction treatment

STAT

Doctors are reporting a troubling trend when it comes to fentanyl. The powerful drug, they say, isn’t just causing overdoses — it’s also making it more difficult to begin addiction treatment. In particular, fentanyl appears more likely to cause severe withdrawal symptoms for patients put on buprenorphine, a key medication used to treat opioid use disorder.

114
114
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Guselkumab Shows Long-Term Improvement in Quality of Life for Patients With Active Psoriatic Arthritis

Pharmacy Times

Guselkumab (Tremfya) is a fully human selective IL-23 inhibitor therapy FDA-approved for the treatment of adults with active psoriatic arthritis and with moderate to severe plaque psoriasis.

FDA 122
article thumbnail

Humana's CenterWell aiming to open at least 30 new clinics next year

Fierce Healthcare

Humana's CenterWell aiming to open at least 30 new clinics next year. pminemyer. Wed, 11/16/2022 - 17:28.

111
111
article thumbnail

FDA Grants EUA to Roche's Real Time PCR Test for Monkeypox Virus

Pharmacy Times

cobas MPXV targets 2 different regions of the monkeypox virus genome that are less prone to mutations than other parts of the genome.

FDA 122
article thumbnail

NICE gives thumbs-down to 5 COVID-19 drugs including AZ's Evusheld and Merck's Lagevrio

Fierce Pharma

NICE gives thumbs-down to 5 COVID-19 drugs including AZ's Evusheld and Merck's Lagevrio. kdunleavy. Wed, 11/16/2022 - 09:44.

106
106
article thumbnail

Teva says medicines access at risk in Northern Ireland

pharmaphorum

The North Ireland Protocol has been a source of tension between the UK and EU since it came into force at the start of 2021 – and according to one pharma company the end of the so-called ‘grace period’ could result in major issues with medicines supply. At a recent hearing in from of the House of Lords on the protocol, Teva UK called for urgent changes to the current iteration of the law, saying that the added regulatory burden that will accompany the end of the grace period will 

article thumbnail

Mission-driven brands seek to answer consumer demands for businesses as a force for good

Drug Store News

Beauty brands are answering demands to do more than sell products.

105
105
article thumbnail

Hope in sight with Apellis’ pegcetacoplan OAKS/DERBY results for GA

pharmaphorum

Last month, pharmaphorum spoke with Dr Charles C. Wykoff about the results from Apellis Pharmaceuticals’ OAKS study on intravitreal pegcetacoplan for geographic atrophy (GA), otherwise known as atrophic or dry age-related macular degeneration (AMD), a leading cause of blindness worldwide. Having presented the data from the 24-month phase 3 trial at the American Academy of Ophthalmology (AAO) annual meeting, Dr Wykoff set aside some time to go into further detail with pharmaphorum about how the r

FDA 106
article thumbnail

Which states have the most overweight, obese populations?

Drug Store News

Colorado has the lowest percentage of obese adults, 25%, which is 1.6 times lower than in West Virginia, the state with the highest at 40.7%.

105
105
article thumbnail

Novartis targets eye, respiratory units for potential sell-offs after Sandoz: Bloomberg

Fierce Pharma

Novartis targets eye, respiratory units for potential sell-offs after Sandoz: Bloomberg. aliu. Wed, 11/16/2022 - 10:15.

104
104
article thumbnail

In country after country, primary care doctors report high burnout and degraded patient care

STAT

The increased stress doctors have faced throughout the Covid-19 pandemic is making some feel like they are providing worse patient care, according to a new survey of primary care physicians from 10 wealthy countries. Younger doctors also reported higher rates of feeling distressed and burned out — a finding that was broadly consistent across the countries included.

article thumbnail

Yet more data underscore the growing risk of suicide among youths

Fierce Healthcare

Yet more data underscore the growing risk of suicide among youths. fdiamond. Wed, 11/16/2022 - 09:16.

103
103
article thumbnail

The scientist behind Pfizer’s Covid vaccine says a flu pandemic is only a matter of time

STAT

BOSTON — Even after leading the charge combating the worst pandemic in a century, vaccine researcher Kathrin Jansen doesn’t feel that she can relax. Another pandemic — this one based on an influenza virus — is inevitable, Jansen said at the annual STAT Summit on Tuesday. “Before SARS-CoV-2, we had worried about pandemic flu.

Vaccines 103
article thumbnail

Virtual physical therapy provider OneStep using smartphones to determine upper-extremity range of motion

Fierce Healthcare

Virtual physical therapy provider OneStep using smartphones to determine upper-extremity range of motion. aburky. Wed, 11/16/2022 - 13:47.

98
article thumbnail

STAT+: Cooling demand for new lab space in Boston could be good news for biotech companies

STAT

Amid a bumpy few years for development in Boston, the business of building lab space has been a gleaming bright spot, with billions upon billions of dollars pouring in to house the region’s booming life science industry. Now, though, even the lab boom is slowing amid a rocky economy, rising interest rates, and soaring construction costs.

103
103
article thumbnail

Rite Aid partners with Grubhub on nationwide delivery

Drug Store News

More than 2,000 Rite Aid locations in 16 states are available on the Grubhub Marketplace for delivery.

98